Clinical Trial Update: Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether atorvastatin has antiviral activity against Hepatitis C virus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED